MCIT Rule Likely Too Broken For CMS To Implement In December, Analyst Predicts
John Leppard with Washington Analysis says the Medicare agency’s recent delay of the MCIT breakthrough devices rule until mid-December suggests the CMS will likely scrap it altogether and start from scratch.
You may also be interested in...
Cures 2.0 Throws MCIT A Lifeline, And More
The second 21st Century Cures Act includes a provision to force the US Medicare agency to cover breakthrough medical devices for elderly patients, among other mandates.
CMS Dashes Industry Hopes For MCIT Rule Any Time Soon
The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.
Expert: AI/ML Pediatric Software Brings Hope – But Also Potential – To Magnifying Disparities
Cognoa’s Sharief Taraman tells Medtech Insight that artificial intelligence and machine learning can help bring new pediatric diagnostics and treatments to market but it’s important to avoid perpetuating racial, gender and other disparities.